Basilea Pharmaceutica AG

Basilea Pharmaceutica AG - PE Ratioverified

BPMUF

Price:

$60.275

Market Cap:

$634.92M

Basilea Pharmaceutica AG is a biopharmaceutical company already generating revenue from its products, which are designed to fulfill medical needs in the challenging areas of cancer (oncology) and infectious diseases (anti-infectives). The company's product portfolio includes Cresemba, an azole antifungal drug administered intravenously or orally. This medication is approved for treating invasive aspergillosis and mucormycosis in both the United States and the European Union. Additionally, Cresemba is undergoing Phase III clinical trials in Japan for addressing invasive fungal infections. Another key product is Zevtera, an antibiotic prescribed for both community-acquired and hospital-acquire...[Read more]

Industry

Biotechnology

IPO Date

2015-06-09

Stock Exchange

OTC

Ticker

BPMUF

The PE Ratio as of June 2026 (TTM) for Basilea Pharmaceutica AG (BPMUF) is 8.47

According to Basilea Pharmaceutica AG’s latest financial reports and current stock price. The company's current PE Ratio is 8.47. This represents a change of 2.36% compared to the average of 8.27 of the last 4 quarters.

Basilea Pharmaceutica AG (BPMUF) Historical PE Ratio (quarterly & annually)

How has BPMUF PE Ratio performed in the past?

The mean historical PE Ratio of Basilea Pharmaceutica AG over the last ten years is -9.27. The current 8.47 PE Ratio has changed -9234.45% with respect to the historical average. Over the past ten years (40 quarters), BPMUF's PE Ratio was at its highest in in the December 2017 quarter at 172.50. The PE Ratio was at its lowest in in the December 2019 quarter at -18.02.

Quarterly (TTM)
Annual

Average

-9.27

Median

-14.31

Minimum

-70.55

Maximum

44.90

Basilea Pharmaceutica AG (BPMUF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Basilea Pharmaceutica AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 194.09%

Maximum Annual PE Ratio = 44.90

Minimum Annual Increase = -163.64%

Minimum Annual PE Ratio = -70.55

Quarterly (TTM)
Annual
YearPE RatioChange
202516.63158.14%
20246.44-84.13%
202340.57-9.64%
202244.90-163.64%
2021-70.5589.82%
2020-37.1764.98%
2019-22.5358.65%
2018-14.20-66.51%
2017-42.40194.09%
2016-14.42-8.82%

Basilea Pharmaceutica AG (BPMUF) Average PE Ratio

How has BPMUF PE Ratio performed in the past?

The current PE Ratio of Basilea Pharmaceutica AG (BPMUF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

21.21

5-year avg

7.60

10-year avg

-9.27

Basilea Pharmaceutica AG (BPMUF) PE Ratio vs. Peers

How is BPMUF’s PE Ratio compared to its peers?

Basilea Pharmaceutica AG’s PE Ratio is less than Viva Biotech Holdings (9.88), greater than Nxera Pharma Co., Ltd. (-8.68), greater than GenSight Biologics S.A. (-1.06), greater than Avisa Diagnostics Inc. (-0.23), less than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (25.01), greater than Valneva SE (-2.84), greater than PureTech Health plc (-3.77), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (13.78), less than Swedencare AB (publ) (84.75), greater than MedinCell S.A. (-26.46),

Build a custom stock screener for Basilea Pharmaceutica AG (BPMUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Basilea Pharmaceutica AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Basilea Pharmaceutica AG (BPMUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Basilea Pharmaceutica AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Basilea Pharmaceutica AG's PE Ratio?

How is the PE Ratio calculated for Basilea Pharmaceutica AG (BPMUF)?

What is the highest PE Ratio for Basilea Pharmaceutica AG (BPMUF)?

What is the 3-year average PE Ratio for Basilea Pharmaceutica AG (BPMUF)?

What is the 5-year average PE Ratio for Basilea Pharmaceutica AG (BPMUF)?

How does the current PE Ratio for Basilea Pharmaceutica AG (BPMUF) compare to its historical average?